ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?

Abstract

Transient ischemic attack (TIA) or a (minor) ischemic stroke increases the risk of a recurrent stroke or death. Antiplatelet therapy with aspirin or clopidogrel is, in the absence of a potential cardiac embolic source, common practice to lower this risk. Until recently, adjuvant dipyridamole or low intensity oral anticoagulation were not generally prescribed in secondary prevention. In this article, we will summarize and discuss the published results of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT). In this trial, treatments with anticoagulants, aspirin alone and the combination of aspirin plus dipyridamole were compared, in a multicenter, three-armed, randomized, open-label study in patients with TIA or minor stroke.

• Authors: R P W Rouhl, J Lodder
• Journal: Expert review of neurotherapeutics (Expert Rev Neurother) Vol. 8 Issue 11 Pg. 1661-5 (Nov 2008) ISSN: 1744-8360 [Electronic] England
• PMID: 18986236 (Publication Type: Journal Article, Review)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Platelet Aggregation Inhibitors
• Dipyridamole
• Aspirin

Topics

• Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
• Aspirin (administration & dosage)
• Dipyridamole (administration & dosage)
• Drug Therapy, Combination
• Female
• Humans
• Ischemic Attack, Transient (drug therapy)
• Male
• Middle Aged
• Multicenter Studies as Topic
• Platelet Aggregation Inhibitors (administration & dosage)
• Randomized Controlled Trials as Topic
• Stroke (drug therapy)